Diagnostic Ultrasound for Palpable Breast Masses

Age-Based Imaging Approach

For women younger than 30 years, ultrasound is recommended as the first-line diagnostic imaging investigation for palpable breast masses due to the low incidence of breast cancer and theoretical increased radiation risk of mammography 1, 2
For women 30-39 years, either diagnostic ultrasound or diagnostic mammography/digital breast tomosynthesis (DBT) can be used as the initial imaging evaluation 1, 3
For women 40 years and older, diagnostic mammography or DBT is recommended as the initial imaging modality, followed by ultrasound in most cases 4

Diagnostic ultrasound allows direct correlation between the palpable abnormality and imaging findings, which is essential for accurate diagnosis 1
It can immediately determine if a breast mass is a fluid collection, solid mass, or complex lesion, guiding therapeutic intervention 5
For masses seen equally well on mammography and ultrasound, ultrasound guidance is preferred for biopsy due to patient comfort, efficiency, absence of radiation, and real-time visualization of the needle 1
Diagnostic ultrasound has a very high negative predictive value for cancer in the evaluation of palpable lumps 2

If diagnostic ultrasound demonstrates a clearly benign finding, clinical follow-up is appropriate without further imaging or tissue sampling 1
If diagnostic ultrasound reveals suspicious features, tissue sampling is warranted 1, 2
If diagnostic ultrasound is negative but clinical suspicion remains high, further evaluation is still necessary as physical examination findings should never be overruled by negative imaging 2

A thorough imaging workup of a palpable mass should be completed prior to biopsy, as changes related to the biopsy may confuse or limit subsequent image interpretation 4, 2
There is little to no role for advanced imaging technologies such as MRI, PET, or molecular breast imaging in the routine initial evaluation of palpable breast masses 1
Core biopsy is superior to fine-needle aspiration in terms of sensitivity, specificity, and correct histological grading of palpable masses 1

Using screening ultrasound instead of diagnostic ultrasound for palpable masses, as diagnostic ultrasound specifically targets the area of concern with direct clinical correlation 1, 2
Proceeding directly to biopsy without imaging evaluation, as imaging helps characterize the mass and guide appropriate management 4, 2
Relying solely on physical examination findings without imaging evaluation, as significant disagreement can occur even among experienced examiners 2

The National Comprehensive Cancer Network recommends ordering diagnostic mammogram first, followed by ultrasound in nearly all cases for women ≥40 years 6
For women 30-39 years, the National Comprehensive Cancer Network suggests ordering both diagnostic mammogram and ultrasound together as initial evaluation 7, 8
In women <30 years, the American College of Radiology recommends ordering ultrasound first without mammogram 6, 9

The National Comprehensive Cancer Network requires ultrasound to guide core needle biopsy for BI-RADS 4-5 findings (suspicious or highly suggestive of malignancy) 7, 8
The National Comprehensive Cancer Network recommends ultrasound to characterize the finding and determine if biopsy is warranted for BI-RADS 0 (need additional imaging) 10
The National Comprehensive Cancer Network mandates ultrasound for any palpable mass to achieve geographic correlation between clinical and imaging findings 7, 8

The National Comprehensive Cancer Network emphasizes the importance of ultrasound in distinguishing solid masses from cysts, guiding immediate therapeutic intervention 7, 10
The American College of Radiology recommends against skipping ultrasound based solely on negative mammogram when clinical suspicion persists 7, 8

The American College of Radiology recommends ultrasound as the primary imaging modality after any concerning clinical finding in pregnant or lactating women 6
The National Comprehensive Cancer Network suggests considering ultrasound as an adjunct to mammography for nipple discharge without palpable mass 10

The National Comprehensive Cancer Network requires ultrasound to demonstrate geographic correlation between the palpable finding and imaging abnormality 7, 11

The American College of Radiology recommends performing imaging before biopsy whenever possible to avoid confusing or altering subsequent imaging interpretation 6, 9
The National Comprehensive Cancer Network advises ordering ultrasound same-day or next-available appointment after suspicious mammogram to avoid delays in diagnosis 7